TY - CHAP M1 - Book, Section TI - Cardiac Arrhythmias, Pacing, Cardioversion, and Defibrillation in the Critical Care Setting A1 - Kuriachan, Vikas P. A1 - Gillis, Anne M. A2 - Schmidt, Gregory A. A2 - Kress, John P. A2 - Douglas, Ivor S. PY - 2023 T2 - Hall, Schmidt and Wood’s Principles of Critical Care, 5th Edition AB - KEY POINTSCorrect diagnoses and understanding of arrhythmia mechanisms are crucial to successful arrhythmia management.The hemodynamic effects of an arrhythmia are important in developing an appropriate treatment strategy.Predisposing conditions and reversible causes should be recognized and corrected.Knowledge of antiarrhythmic drugs for prophylaxis, acute management, and long-term management are necessary for successful arrhythmia management.The proarrhythmic potential of antiarrhythmic drugs must be recognized and preventive measures taken whenever possible.Knowledge of antiarrhythmic drug pharmacokinetics and pharmacodynamics and the impact of multisystem organ disease on these parameters are important in preventing drug toxicity.The intensivist should be skilled in the implantation of temporary pacing systems, external cardioversion, and defibrillation.Role of cardiac pacing, electrical cardioversion, and defibrillation should be clear to physicians managing patients with arrhythmias.Recognition of malfunctioning temporary and permanent implantable pacemakers or cardioverter defibrillators is crucial in the management of patients with such devices. SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/10/04 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1201801281 ER -